[Diagnostic value of a new myocardial perfusion agent, 99mTc-teboroxime (SQ30,217) in patients with coronary artery disease, utilizing a SPECT imaging protocol: a multicenter phase III clinical trial].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples